Aminoglycoside Antibacterial
An Established Pharmacologic Class (EPC) in the FDA NDC Directory: the class FDA records for a product in its PHARM_CLASSES field.
In the NADAC file of 2026-10-14
34 products in the NADAC file of 2026-10-14 have an NDC that FDA lists in this class, covering 35 nonproprietary names as FDA writes them. 10 of them have a Medicare figure on OpenBill.
Being in one class means FDA describes the drugs’ pharmacology the same way. It does not mean one can replace another; that is a question for your prescriber.
Prices per unit: CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · as of 2026-10-14 · retrieved 2026-10-17. Classes: FDA NDC Directory · ndctext.zip · as of 2026-10-16.
The products, with what pharmacies pay per unit
- AMIKACIN SULF 500 MG/2 ML VIAL
- CORTISPORIN-TC EAR SUSPENSION
- FT ANTIBIOTIC-PAIN RELIEF CRM
- FT TRIPLE ANTIBIOTIC OINTMENT
- FT TRIPLE ANTIBIOTIC-PAIN OINT
- GENTAMICIN 0.1% CREAM
- GENTAMICIN 0.1% OINTMENT
- GENTAMICIN 0.3% EYE DROP
- GENTAMICIN 80 MG/2 ML VIAL
- GNP ANTIBIOTIC-PAIN RELIEF CRM
- GS FIRST AID ANTIBIOTIC OINT
- NEO-BACIT-POLY-HC EYE OINTMENT
- NEOMYC-BACIT-POLYMIX EYE OINT
- NEOMYC-POLYM-DEXAMET EYE OINTM
- NEOMYC-POLYM-DEXAMETH EYE DROP
- NEOMYC-POLYM-GRAMICID EYE DROP
- NEOMYCIN 500 MG TABLET
- NEOMYCIN-POLY-HC EYE DROPS
- NEOMYCIN-POLYMYXIN-HC EAR SOLN
- NEOMYCIN-POLYMYXIN-HC EAR SUSP
- QC TRIPLE ANTIBIOTIC OINTMENT
- TOBRADEX EYE OINTMENT
- TOBRADEX ST 0.3-0.05% EYE DROP
- TOBRAMYCIN 0.3% EYE DROP
- TOBRAMYCIN 300 MG/5 ML AMPULE
- TOBRAMYCIN 80 MG/2 ML VIAL
- TOBRAMYCIN-DEXAMETH OPHTH SUSP
- TOBRAMYCIN-LOTEPREDNOL 0.3%-0.5% EYE DROP
- TOBREX 0.3% EYE OINTMENT
- TRIPLE ANTIBIOTIC OINTMENT
- TRIPLE ANTIBIOTIC OINTMENT PKT
- TRIPLE ANTIBIOTIC PLUS OINT
- TRIPLE ANTIBIOTIC PLUS OINTMNT
- ZYLET EYE DROPS
How to read these prices
OpenBill holds every page to these five rules, written by the project’s owner and quoted word for word:
- A price is a range to expect, never a quote.
- Medicare's price is not your price. Say so on every screen that shows it.
- State which dataset and which effective date produced every figure.
- If a source is stale or a file is empty, show that rather than a zero.
- Disclaimer footer: not medical advice, no warranty, other people's data can be wrong.